Trade AstraZeneca ^AZN

AstraZeneca Stock And 2 Value Picks Trading Below Cash Flow Estimates

Parallel Advisors LLC Invests $1.72 Million in Astrazeneca Plc $AZN

Temasek Holdings Private Ltd Takes $70.89 Million Position in Astrazeneca Plc $AZN - Stock Observer

Astrazeneca Plc $AZN Shares Sold by Saturna Capital Corp - Daily Political

Does Eplontersen's Phase 3 Miss and Dravet Progress Change The Bull Case For Ionis (IONS)?

FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells

PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight

AstraZeneca Stock And 2 UK Shares Trading Below Cash Flow Value

Burling Wealth Partners LLC Buys Shares of 12,554 Astrazeneca Plc $AZN - Markets Daily

Former AstraZeneca and Novo Nordisk executives join ELRIG Scientific Advisory Board

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

AstraZeneca Stock And Two UK Value Shares Trading Below Cash Flow Estimates

Astrazeneca Plc $AZN Shares Sold by Boston Common Asset Management LLC

Astrazeneca Plc $AZN Shares Acquired by DekaBank Deutsche Girozentrale

Astrazeneca (AZN) to Release Quarterly Earnings on Monday

AZN Q2 2026 Earnings Report on 7/27/2026

Erste Group Bank Cuts Earnings Estimates for Astrazeneca

AstraZeneca inks $1.5 B deal with China's Dizal Pharma for novel oral EGFR inhibitor Zegfrovy for lung cancer

50,765 Shares in Astrazeneca Plc $AZN Purchased by S&CO Inc.

5,954,417 Shares in Astrazeneca Plc $AZN Purchased by SEB Asset Management AB

Swiss National Bank Takes $1.20 Billion Position in Astrazeneca Plc $AZN - Markets Daily

Jennison Associates LLC Sells 2,698,901 Shares of Astrazeneca Plc $AZN

6,174,666 Shares in Astrazeneca Plc $AZN Bought by Swiss National Bank - Stock Observer

10,918 Shares in Astrazeneca Plc $AZN Purchased by Spartan Wealth Advisory Services LLC - Daily Political

AstraZeneca Stock And 2 Cash Flow Picks Trading Below Fair Value

SEB Asset Management AB Makes New $1.16 Billion Investment in Astrazeneca Plc $AZN - Daily Political

Aurora Investment Counsel Takes $2.53 Million Position in Astrazeneca Plc $AZN

Assetmark Inc. Has $37.69 Million Stake in Astrazeneca Plc $AZN

Is a £500k Stocks and Shares ISA enough to retire in style?

Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch?

Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

AstraZeneca Stock And Two UK Cash Flow Picks Trading Below Fair Value

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

SouthState Bank Corp Sells 63,327 Shares of Astrazeneca Plc $AZN

Barings LLC Makes New $27.79 Million Investment in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Stake Reduced by Nwam LLC - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Attractive Growth Profile Positions AstraZeneca PLC (AZN) as Opportunity

Attractive Growth Profile Positions AstraZeneca PLC (AZN) as an Investment Bet

Astrazeneca Plc $AZN Position Lowered by Marks Group Wealth Management Inc

Principal Financial Group Inc. Decreases Position in Astrazeneca Plc $AZN

AZN: Trial Setbacks And Oncology Deals Will Shape Medium Term Credibility

Astrazeneca Plc $AZN Shares Sold by Marks Group Wealth Management Inc - Daily Political

ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS)

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models

Checchi Capital Advisers LLC Decreases Stake in Astrazeneca Plc $AZN

169,590 Shares in Astrazeneca Plc $AZN Purchased by Maryland State Retirement & Pension System

Checchi Capital Advisers LLC Trims Stake in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by Calamos Advisors LLC

AMG National Trust Bank Has $4.72 Million Stake in Astrazeneca Plc $AZN - Zolmax

Calamos Advisors LLC Trims Position in Astrazeneca Plc $AZN - Stock Observer

Recent Research Analysts' Ratings Changes for Astrazeneca (AZN) - Daily Political

Maryland State Retirement & Pension System Buys Shares of 169,590 Astrazeneca Plc $AZN - Daily Political

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma

Promising Manufacturing Stocks To Research - July 14th - Zolmax

4568: Tumor Agnostic Oncology Approvals In Europe Will Drive Future Upside Potential

Sequoia Financial Advisors LLC Sells 19,406 Shares of Astrazeneca Plc $AZN - Zolmax

HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead

IP Federation elects Philips licensing leader as new president

Samsung Electronics denies report that it is exploring US listing

AstraZeneca Secures $1.5 Billion Licensing Deal for Revolutionary Lung Cancer Drug Zegfrovy from China's Dizal Pharma, ETPharma

Astrazeneca Plc $AZN Shares Bought by Diversify Wealth Management LLC

Bleakley Financial Group LLC Sells 23,183 Shares of Astrazeneca Plc $AZN

AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill

AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion | Morningstar

Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

Dizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy

Calamos Wealth Management LLC Sells 4,322 Shares of Astrazeneca Plc $AZN - Stock Observer

Carnegie Investment Counsel Reduces Position in Astrazeneca Plc $AZN - Daily Political

AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN) | Morningstar

HSBC downgrades AstraZeneca after key trial failure

AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'

Astrazeneca Plc $AZN Shares Sold by Triglav Investments D.O.O.

Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Citizens National Bank Trust Department Sells 13,426 Shares of Astrazeneca Plc $AZN - Daily Political

AstraZeneca Stock And 2 UK Value Shares Trading Below Cash Flow Estimates

AstraZeneca helps spark £3bn UK life sciences investment boom

Pittenger & Anderson Inc. Sells 32,448 Shares of Astrazeneca Plc $AZN

Rossmore Private Capital Sells 32,709 Shares of Astrazeneca Plc $AZN

AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage

Ionis Pharmaceuticals (IONS) Faces A Key Setback As Eplontersen Misses In Phase 3

Money Concepts Capital Corp Lowers Stake in Astrazeneca Plc $AZN

AstraZeneca Stock And 2 UK Cash Flow Picks Trading Below Fair Value

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) After Rival ATTR-CM Setback And New Partnerships

AstraZeneca's trial flop raises bigger questions around its pipeline

Is Alnylam Pharmaceuticals (ALNY) Cheap As Rival Trial Failure Shifts ATTR CM Expectations?

Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Top Pharmaceutical Stocks To Follow Now - July 10th

Manufacturing Stocks Worth Watching - July 10th - Stock Observer

Alphabet (GOOGL) Stock Forecast 2026–2030: Where Could Google Stock Go as AI Spending Accelerates?

Morning Notes:UK dominates the news headlines this week

US Dollar Forecast 2026 (H2 Outlook): Will the USD Stay Strong Through Year-End?

Nvidia Stock Prediction 2030: Will It Hit a $10 Trillion Market Cap?

Week Ahead: The PBoC and the ECB are set to deliver interest rates

How to Open a Markets.com Demo Account? | 2026 Guide

Markets.com Review 2026: Is It the Best CFD Trading Platform?

Nasdaq 100 Forecast: Index Tests Critical Resistance Amid Cooler Inflation and Resurgent Geopolitical Risks

8 Best Interactive Brokers Alternatives in 2026 (Ranked by Fees & Usability)

5 Best eToro Alternatives 2026: Lower Fees & Better Spreads

Gold Price Today, July 23: Gold Holds Above $4,100 as Oil Rally Limits Gains

Fed Rate Decision Preview: Will the Fed Raise Rates at the July 29, 2026 Meeting?

Crude Oil Prices Rise 2% to Six-Week High as US-Iran Tensions Escalate

Bitcoin Price Forecast: BTC Slips as Rising Oil Prices Renew Inflation Concerns

KOSPI Jumps More Than 3% as Alphabet’s $200 Billion AI Plan Lifts Chip Stocks

Tesla 2026 Q2 Earnings: Revenue Surges 26% as AI Investments Weigh on Profits and Cash Flow

Google 2026 Q2 Earnings: Cloud Revenue Soars 82% as AI Investments Drive Growth Despite Rising Capital Spending

Crude Oil Price Forecast for Next Week: Will WTI and Brent Extend Their Rally?